comparemela.com

Candid Powder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Pharmaceuticals : Q1FY 2023-24 -Today at 06:05 am

Glenmark Pharmaceuticals : Q4FY 2022-23

Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY for Q1 FY 2021-22

Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.